| Patient | Frederick Cook |
|---|---|
| Date of birth | 1865-06-10 |
| Identifiers | MRN HR-EX006-SYN-TD; SSN (made up) 000-06-4471 |
| Document date | 1930-10-27 |
| Author | Harriet Okafor-Brandt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Sixteen-week review of blood pressure, potassium and kidney function four weeks after starting losartan; mood and stroke prevention. [S]
Mr. Cook returns four weeks after changing from hydrochlorothiazide to losartan 50 mg, with amlodipine 5 mg, atorvastatin 40 mg and aspirin 81 mg. He has no dizziness, cough or swelling, and no gout. His home readings average 124/76. He did not have the blood test that was meant to be done one to two weeks after starting losartan; it was drawn this morning. His prison medical records have arrived and record no earlier diagnoses or vaccinations. His fecal immunochemical test was negative. He feels more settled, is writing every morning, and still feels a sting of shame when he is recognized, though it troubles him less. He has had no stroke symptoms. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Average 124/76 |
| Medicine effects | No dizziness, cough or swelling; no gout |
| Records | Prison records received; no earlier diagnoses or vaccinations recorded |
| Screening | Fecal immunochemical test negative |
| Mood | More settled; PHQ-9 4 |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Respiratory | Negative | No cough |
| Neurological | Negative | No weakness, numbness, speech trouble, loss of vision, or dizziness |
| Musculoskeletal | Negative | No joint pain or muscle aches |
| Psychiatric | Negative | Mood better; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morning | once daily in the morning | Oral route | 1930-07-21 to 1930-09-29 | completed | S |
| Amlodipine 5 mg tablet, one tablet by mouth daily | once daily | Oral route | 1930-07-21 | active | S |
| Atorvastatin 40 mg tablet, one tablet by mouth daily | once daily | Oral route | 1930-07-21 | active | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | once daily | Oral route | 1930-07-21 | active | S |
| Losartan 50 mg tablet, one tablet by mouth daily | once daily | Oral route | 1930-09-29 | active | S |
| Colchicine 0.6 mg tablet: two tablets at once, one more an hour later, then one tablet twice a day until the flare settles, for up to a week | 1.2 mg, then 0.6 mg an hour later, then 0.6 mg twice daily for up to a week | Oral route | 1930-09-08 to 1930-09-13 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1930-10-27 | Body height | 175 | cm | S |
| 1930-10-27 | Body weight | 74.8 | kg | S |
| 1930-10-27 | Body mass index (BMI) [Ratio] | 24.4 | kg/m2 | S |
| 1930-10-27 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1930-10-27 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1930-10-27 | Heart rate | 66 | /min | S |
| 1930-10-27 | Respiratory rate | 14 | /min | S |
| 1930-10-27 | Body temperature | 36.6 | Cel | S |
| 1930-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1930-10-27 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 136-145 mmol/L | Normal | S |
| 1930-10-27 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1930-10-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.06 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1930-10-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 78 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1930-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |
Vital signs recorded on 1930-10-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 126/76, pulse 66, weight 74.8 kg |
| Neck | Soft right carotid bruit, unchanged |
| Cardiovascular | Regular rhythm; no ankle edema |
| Psychiatric | Brighter; engaged and humorous |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at the first visit, 166/94 mmHg (average of two seated readings), without a previous diagnosis of hypertension; no symptoms; out-of-office confirmation with a week of home readings requested | resolved | confirmed | R03.0 | S — Synthetic presenting finding at re-entry; superseded by the diagnosis at the second visit. |
| Essential hypertension, stage 2, confirmed by home readings averaging 154/90 mmHg; no left ventricular hypertrophy on ECG; urine albumin normal | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. |
| Right carotid bruit heard at the first visit in a man with no symptoms of stroke or transient ischemic attack; carotid duplex ultrasound and vascular neurology consultation requested | resolved | confirmed | R09.89 | S — Synthetic examination finding; superseded by the duplex result at the second visit. |
| Asymptomatic atherosclerotic stenosis of the right internal carotid artery, 50 to 69 percent by duplex ultrasound, with less than 50 percent plaque on the left; no stroke or transient ischemic attack; managed with best medical therapy (blood pressure control, a statin and low-dose aspirin) and yearly duplex surveillance | active | confirmed | I65.21 | S — Synthetic modern diagnosis made at the vascular neurology consultation; not a claim about his real arteries. |
| Recent release from about six years of incarceration: re-entering community life on parole at 65, establishing primary care with no medical records yet received, a rented room, no earned income, and a public reputation he feels as a burden | active | confirmed | Z65.2 | S — Synthetic modern social problem anchored to his documented imprisonment and parole. |
| Acute gout of the right first metatarsophalangeal joint, a first flare seven weeks after starting hydrochlorothiazide, diagnosed clinically (sudden overnight onset, redness, swelling and exquisite tenderness of the big toe, no fever); treated with low-dose colchicine; resolved | resolved | confirmed | M10.271 | S — Synthetic adverse drug effect; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, seated, average of two readings | Every visit | Completed today | 126/76 mmHg; at target |
| Self-management | Home blood pressure monitoring | At diagnosis and after each treatment change | Completed today | Average 124/76 |
| Laboratory | Sodium, potassium, creatinine and eGFR | Baseline; early after starting a diuretic or an ARB; then every 6 months | Completed today | Sodium 139, potassium 4.5 mmol/L, creatinine 1.06 mg/dL, eGFR 78. Protocol deviation: the potassium and creatinine check ordered for one to two weeks after starting losartan was not drawn, because no date was booked and no visit fell in that window; it was drawn today, four weeks after starting. No harm resulted: potassium is normal and creatinine rose only 0.02 mg/dL. Corrective action: book the blood test with a date when a renin-angiotensin drug or a diuretic is started |
| Laboratory | Lipid panel | Baseline; 4 to 12 weeks after starting a statin; then every 3 to 12 months | Up to date | LDL 68 mg/dL four weeks ago; next in 6 to 12 months |
| Laboratory | Urine albumin-to-creatinine ratio | Annually | Up to date | 18 mg/g at intake; next due at the annual visit |
| Laboratory | HbA1c or fasting glucose | Annually | Up to date | HbA1c 5.5% at intake |
| Medication safety | ARB effects: dizziness, potassium, creatinine | Early after starting, then every visit | Completed today | No dizziness; potassium and creatinine normal |
| Medication safety | Antiplatelet adherence and bleeding | Every visit | Completed today | No bleeding |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | No muscle symptoms |
| Imaging | Carotid duplex ultrasound for known 50 percent or greater stenosis on medical therapy | At diagnosis, then yearly | Up to date | Next duplex due in about nine months |
| Examination | Peripheral pulses and ankle-brachial index | Every 2 to 3 years at 65 or older | Due | Ankle-brachial index at the annual wellness visit |
| Self-management | Stroke warning signs (BE FAST) and calling 911 | Every visit | Completed today | No symptoms; knows the signs |
| Survey | Depression screen (PHQ-9) | Annually | Completed today | PHQ-9 4, from 7 at intake |
| Self-management | Re-entry social needs: housing, income, benefits, records | Every visit until settled | Completed today | Settled; records received |
Goal progress:
Immunizations given today: Influenza vaccine, high-dose, trivalent; Recombinant zoster vaccine, dose 2 of 2 [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026); 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024); Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease (AbuRahma AF, et al. J Vasc Surg 2022;75(1S):4S-22S) (2021); 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018); Adult Immunization Schedule by Age (2026)
Follow-up: Review in three months, with home readings. Annual wellness visit next summer. Repeat carotid duplex in about nine months. [S]